Welcome to our dedicated page for Zoetis news (Ticker: ZTS), a resource for investors and traders seeking the latest updates and insights on Zoetis stock.
Zoetis Inc. reports developments as a global animal health company serving veterinarians, livestock producers and pet owners. Its updates center on medicines, vaccines, diagnostics, biopharmaceuticals and digital solutions for companion animals and livestock, organized commercially through U.S. and International segments.
Recurring news includes quarterly results and guidance, dividend declarations, investor conference presentations, pipeline and product-regulatory updates, and portfolio activity tied to animal health innovation. Company materials also describe R&D work across areas such as chronic kidney disease, oncology, cardiology, anxiety and obesity, as well as approved long-acting osteoarthritis pain products Lenivia and Portela.
Zoetis released its 2023 Sustainability Report, highlighting advancements in its 'Driven to Care' strategy. Key achievements include:
1. Increasing volunteer work by 81% to 16,611 hours.
2. Supporting 28 initiatives with $8.3 million in grants across 19 countries.
3. Launching innovative diagnostics, vaccines, and parasiticides for livestock producers.
4. Utilizing over 30% renewable electricity with on-site solar arrays at seven facilities, aiming for 100% by 2030.
5. Replacing rabies vaccine packaging plastic with paperboard, reducing PVC use by 8.0 metric tons annually.
Zoetis invested $7 million in community programs, reaching 202,000 pet owners and impacting 91,000 animals. The company also received eight awards for fostering an inclusive culture and expanded its Leading@Zoetis program to over 2,000 leaders globally.
Zoetis aims to achieve carbon neutrality by 2030, reporting 32.6% renewable electricity use, completing 38 energy efficiency projects, and reducing Scope 1 and 2 emissions by 18.9% since 2021.
The Board of Directors at Zoetis (NYSE: ZTS) has announced a dividend of $0.432 per share for the third quarter of 2024.
This dividend will be disbursed on September 4, 2024, to all shareholders of record as of July 18, 2024. The company continues its commitment to returning value to its shareholders through regular dividend payments.
Zoetis (NYSE: ZTS) will attend the William Blair 44th Annual Growth Stock Conference on June 4, 2024.
Wetteny Joseph, Executive Vice President and CFO, will represent the company and answer analysts' questions. His presentation is scheduled for 2:40 p.m. CT.
Investors and interested parties can access the live audio webcast of the presentation via the Zoetis investor relations website. A replay will be available following the event.
Zoetis (NYSE: ZTS) will participate in the Stifel 2024 Jaws and Paws Conference on May 29, 2024. Kristin Peck, CEO, will represent the company and respond to analysts' questions. Her presentation is scheduled for 12:05 p.m. ET and will be available via a live audio webcast on the Zoetis investor website. A replay will also be accessible after the event.
Zoetis Inc. (NYSE:ZTS) reported a successful first quarter of 2024 with revenue of $2.2 billion, a 10% increase YoY. Net income was $599 million, or $1.31 per diluted share, up 9% and 10%, respectively. Adjusted net income was $634 million, or $1.38 per diluted share. The company updated its full-year 2024 revenue guidance to $9.050 - $9.200 billion, showing operational revenue growth of 8.5% to 10.5%. Zoetis continues to invest in innovation and growth, expanding product franchises globally.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.